Advanced Pharmaceutical Excipients Used in Solid Dosage Forms
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 110
Special Issue Editors
Interests: liquisolid systems; co-processed excipients; melt granulation; hot melt coating; multiparticulates; fluid bed; solid dosage forms
Special Issues, Collections and Topics in MDPI journals
Interests: quality by design; oral drug delivery; solid dosage forms; artificial intelligence; modified drug release; multiparticulates; process optimization
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Solid dosage forms are the most common dosage forms on the market and are preferred by both manufacturers and patients. The importance of excipients, which usually account for the majority of the total mass of a drug product, is well known and is related to various aspects, including the manufacturability, stability and (bio)performance of the drug product. Recent advances and new trends in solid dosage form manufacturing and formulation are targeting advanced and highly functional excipients. Some of the key trends in solid dosage form manufacturing are related to improving the speed of manufacturing equipment, the application of more cost-effective and environmentally friendly technologies and the increasing interest in continuous processing, all of which require improvements in excipient functionality and lot-to-lot consistency. On the other hand, new formulation approaches that address the major challenge posed by the increasing number of poorly soluble APIs, or the need to improve patient compliance through patient-tailored solid dosage forms, further highlight the need for new, multifunctional excipients.
This Special Issue focuses on recent advances in the development of excipients with high functionality for solid dosage forms and the methods used to characterize them.
Dr. Ivana Aleksić
Prof. Dr. Jelena Djuris
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- solid dosage forms
- co-processed excipients
- mesoporous materials
- multifunctional excipients
- directly compressible
- high-functionality excipients
- bioavailability enhancement
- continuous processing
- patient compliance
- sustainability
- poor solubility
